Get the Stockscreener App
0.3036
1.69%
0.0086
Quoin Pharmaceuticals Ltd Adr stock is traded at $0.3036, with a volume of 53,645.
It is up +1.69% in the last 24 hours and down -2.71% over the past month.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
See More
Previous Close:
$0.295
Open:
$0.295
24h Volume:
53,645
Relative Volume:
0.01
Market Cap:
$2.50M
Revenue:
-
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.0546
EPS:
-5.56
Net Cash Flow:
$-7.99M
1W Performance:
-3.16%
1M Performance:
-2.71%
6M Performance:
-50.11%
1Y Performance:
-70.00%
1-Day Range:
$0.2923
$0.3088
1-Week Range:
$0.2703
$0.3177
52-Week Range:
$0.2703
$1.57
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Name
Quoin Pharmaceuticals Ltd Adr
Sector
Industry
Phone
97299741444
Address
23 HATA'AS STREET, KFAR SABA
Compare QNRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
0.2985 | 2.50M | 0 | -8.28M | -7.99M | -5.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
508.46 | 130.68B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.09 | 74.97B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.43 | 36.08B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.57 | 31.19B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.79 | 27.56B | 3.32B | -860.46M | -1.04B | -8.32 |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa
NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater
Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com India
Stock Performance Spotlight: Quoin Pharmaceuticals Ltd ADR (QNRX) Ends the Day at 0.31, Down by -2.06 - The Dwinnex
Is Energy Services of America Corp (NASDAQ: ESOA) Poised For Further Gains At A 45.82% Distance From The Low? - Marketing Sentinel
Should You Expect Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) To Recover From Its 9.68% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel
BTC Digital Ltd (NASDAQ: BTCT): Can A Stock Be Up 21.97% YTD, And Still Be A Loser - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Aurora Mobile Ltd ADR (NASDAQ: JG) Stock Gained 83.28% Over A Month – Any Room To Run? - Marketing Sentinel
Now Is The Time To Build A Position In Atyr Pharma Inc (NASDAQ:ATYR) - Marketing Sentinel
Berry Global Group Inc [BERY] Records 200-Day SMA of $64.89 - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
INVZ Shares Experience Surge in Value - Knox Daily
Jefferies Financial Group Inc [JEF] Shares Rise 1.55 % on Thursday - Knox Daily
DHT Holdings Inc [DHT] Shares Jump Approximately 9.62% Over the Year - Knox Daily
Now Is The Time To Build A Position In American Battery Technology Company (NASDAQ:ABAT) - Marketing Sentinel
After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel
Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel
Orangekloud Technology Inc (NASDAQ: ORKT) Up 58.11% From 52-Week Low; YTD Falls -50.99% – Here’s What To Do Now – Marketing Sentinel - Marketing Sentinel
Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
PDD Holdings Inc ADR (NASDAQ: PDD): How To Buy And When To Buy And Its Performance & Trends - Marketing Sentinel
Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com India
Understanding QNRX’s financial ratios: A beginner’s guide - US Post News
An Overview of Castellum Inc (AMEX: CTM)’s Stock Performance and Outlook - Marketing Sentinel
Why Should You Invest In Castellum Inc (AMEX: CTM)? - Marketing Sentinel
FTAI Infrastructure Inc (NASDAQ:FIP) Shares Dropped -1.13% In A Week. Can It Continue Rising? - Marketing Sentinel
Capricor Therapeutics Inc (NASDAQ:CAPR) Decline -1.05%, More Rally Possible - Marketing Sentinel
Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - MSN
AST SpaceMobile Inc (ASTS) Investors Will See A Big Return Again - Marketing Sentinel
Why Acquire Shares Of Castellum Inc (CTM)? - Marketing Sentinel
Syros Pharmaceuticals Inc (NASDAQ: SYRS) Fell -2280.95%, Predicting What To Expect In The Near Future - Marketing Sentinel
Sobr Safe Inc (NASDAQ: SOBR) Fall -93.95% In Six Months, Here’s What We Should Expect Now - Marketing Sentinel
Future Prospects And Stock Pricing Of DatChat Inc (NASDAQ: DATS) - Marketing Sentinel
Future Outlook And Stock Price Performance For Zeo Energy Corp (NASDAQ: ZEO) - Marketing Sentinel
Future Outlook And Stock Price Performance For Evaxion Biotech A/S ADR (NASDAQ: EVAX) - Marketing Sentinel
Now Is The Time To Build A Position In Pony AI Inc. ADR (NASDAQ:PONY) - Marketing Sentinel
Should You Expect Humacyte Inc (NASDAQ:HUMA) To Recover From Its 44.64% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In MGO Global Inc (NASDAQ:MGOL) - Marketing Sentinel
Now Is The Time To Build A Position In XORTX Therapeutics Inc (NASDAQ:XRTX) - Marketing Sentinel
Quoin reports progress in pediatric skin disorder study - Investing.com
Worksport Ltd (NASDAQ: WKSP) Is Under Pressure Due To Weak Fundamental Momentum. - Marketing Sentinel
Third Harmonic Bio Inc (NASDAQ:THRD) Shares Rebounded 3.35% From Their Lows – But Can They Continue? - Marketing Sentinel
fuboTV Inc (NYSE:FUBO) Shares Surged 288.30% In A Week – But Will They Keep Going Up? - Marketing Sentinel
Now Is The Time To Build A Position In Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) - Marketing Sentinel
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials - GlobeNewswire Inc.
Analysts Are Recommending Greenwave Technology Solutions Inc (GWAV) As A Buy Candidate - Marketing Sentinel
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Myers Michael | Chief Executive Officer |
Dec 23 '24 |
Buy |
0.45 |
555,556 |
250,000 |
602,808 |
| Dunn Gordon | Chief Financial Officer |
Dec 23 '24 |
Buy |
0.45 |
122,221 |
54,999 |
151,077 |
| Culverwell Anthony James | Director |
Dec 23 '24 |
Buy |
0.45 |
100,000 |
45,000 |
100,317 |
| Dunn Gordon | Chief Financial Officer |
Sep 10 '24 |
Buy |
0.81 |
20,000 |
16,200 |
28,856 |
| Dunn Gordon | Chief Financial Officer |
Sep 09 '24 |
Buy |
0.79 |
8,856 |
7,005 |
8,856 |
| Carter Denise P. | Chief Operating Officer |
Sep 04 '24 |
Buy |
0.78 |
31,813 |
24,912 |
47,092 |
| Carter Denise P. | Chief Operating Officer |
Sep 03 '24 |
Buy |
0.65 |
5,922 |
3,825 |
15,279 |
| Myers Michael | Chief Executive Officer |
Sep 04 '24 |
Buy |
0.77 |
37,094 |
28,421 |
47,252 |
| Myers Michael | Chief Executive Officer |
Sep 03 '24 |
Buy |
0.62 |
800 |
495 |
10,158 |
| LANGER DENNIS | Director |
Jun 07 '24 |
Sale |
0.73 |
297 |
217 |
53 |
1.28%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):